KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cvs Health (CVS) Change in Account Payables (2016 - 2025)

Historic Change in Account Payables for Cvs Health (CVS) over the last 17 years, with Q4 2025 value amounting to $10.3 billion.

  • Cvs Health's Change in Account Payables rose 378.24% to $10.3 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $37.6 billion, marking a year-over-year decrease of 322.25%. This contributed to the annual value of $37.6 billion for FY2025, which is 322.25% down from last year.
  • Per Cvs Health's latest filing, its Change in Account Payables stood at $10.3 billion for Q4 2025, which was up 378.24% from $8.7 billion recorded in Q3 2025.
  • In the past 5 years, Cvs Health's Change in Account Payables ranged from a high of $11.4 billion in Q2 2024 and a low of $6.2 billion during Q2 2022
  • In the last 5 years, Cvs Health's Change in Account Payables had a median value of $8.7 billion in 2023 and averaged $8.8 billion.
  • As far as peak fluctuations go, Cvs Health's Change in Account Payables surged by 4812.37% in 2024, and later tumbled by 1316.5% in 2025.
  • Quarter analysis of 5 years shows Cvs Health's Change in Account Payables stood at $9.8 billion in 2021, then rose by 1.24% to $9.9 billion in 2022, then fell by 12.45% to $8.7 billion in 2023, then rose by 13.69% to $9.9 billion in 2024, then increased by 3.78% to $10.3 billion in 2025.
  • Its last three reported values are $10.3 billion in Q4 2025, $8.7 billion for Q3 2025, and $9.9 billion during Q2 2025.